Comparative Effectiveness Research Begins with $1B from Stimulus | GenomeWeb

NEW YORK (GenomeWeb News) – When President Barack Obama included over $1 billion in the federal stimulus spending bill in February to study which healthcare treatments are most beneficial for most patients and most cost-effective, he signaled that comparative effectiveness research likely will be part of his administration's effort to change the healthcare system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.